Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Penicillamine in rheumatoid arthritis

Layton, M.A., et al., "The Therapeutic Response to D-Penicillamine in Rheumatoid Arthritis Influence of Glutathione S-Transferase Polymorphisms," Rheumatology (Oxford), 38, 43-47 (1999). [Pg.186]

Rheumatoid arthritis-The mechanism of action of penicillamine in rheumatoid arthritis is unknown. The onset of therapeutic response may not be seen for 2 or 3 months in those patients who respond. [Pg.652]

Taylor HG, Samanta A. Penicillamine in rheumatoid arthritis. A problem of toxicity. Drug Saf 1992 7(l) 46-53. [Pg.2746]

Dubost JJ, Soubrier M, Bouchet F, Kemeny JL, Lhopitaux R, Bussiere JL, Sauvezie B. Complications neuromusculaires de la D-penicillamine dans la polyarthrite rhumatoide. [Nemomuscular complications of D-penicillamine in rheumatoid arthritis.] Rev Nemol (Paris) 1992 148(3) 207-11. [Pg.2748]

Masson C, Bregeon C, Ifrah N, Berton V, Housseau F, Renier JC. Syndrome d Evans sous D-penicillamine au cours d une polyarthrite rhumatoi de. Interet de I associa-tion corticoi des-danazol. [Evans syndrome caused by D-penicillamine in rheumatoid arthritis. Value of the corticoids-danazol combination.] Rev Rhum Mai Osteoartic 1991 58(7) 519-22. [Pg.2750]

Stein HB, Patterson AC, Offer RC, Atkins CJ, Teufel A, Robinson HS. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Intern Med 1980 92(l) 24-9. [Pg.2754]

Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. J Rheumatol 1984 11(5) 610-14. [Pg.2756]

Mbuyi-Muamba JM, Dequeker J. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis. Clin Rheumatol 1983 2(4) 369-74. [Pg.3428]

Manthrope R, Florbov S, Sylvest J, Vinterberg FI. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Scand J Rheumatol 1986 15 13-22. [Pg.475]

Kean WF, Lock CJL, Floward-Lock FIE, Buchanan WW. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis. Arthritis Rheum 1982 25 917-922. [Pg.475]

Weiss AS, Markenson JA, Weiss MS, Kammerer WEI. Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephritic syndrome. Am J Med 1978 64 114-120. [Pg.476]

Hill HFH, Hill AGS, Day AT, Brown RM, Golding JR, Eyie WH. Maintenance dose of penicillamine in rheumatoid arthritis A comparison between standard and a response-related flexible regimen. Ann Rheum Dis 1979 38 429-433. [Pg.476]

Felix-Davies DD, Stewart AM, Wilkinson BR, Bateman JR, Delamere JR A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis. Am J Med 1983 75(6A) 138-141. [Pg.321]

Seideman P, Lindstrom B. Fliarmacokinetic intemctions of penicillamine in rheumatoid arthritis. JR/ieMmato/( 1989) 16,473-4. [Pg.1267]

See other pages where Penicillamine in rheumatoid arthritis is mentioned: [Pg.150]    [Pg.465]    [Pg.293]    [Pg.1129]   
See also in sourсe #XX -- [ Pg.33 , Pg.39 , Pg.351 , Pg.361 ]

See also in sourсe #XX -- [ Pg.33 , Pg.39 , Pg.351 , Pg.361 ]

See also in sourсe #XX -- [ Pg.293 ]

See also in sourсe #XX -- [ Pg.375 , Pg.376 , Pg.377 , Pg.378 ]



SEARCH



Arthritis, rheumatoid

D-Penicillamine in rheumatoid arthritis

In rheumatoid arthritis

Penicillamin

Penicillamine

Rheumatoid

© 2024 chempedia.info